Skibinska, M.; Kapelski, P.; Dmitrzak-Weglarz, M.; Lepczynska, N.; Pawlak, J.; Twarowska-Hauser, J.; Szczepankiewicz, A.; Rajewska-Rager, A.
Elevated Epidermal Growth Factor (EGF) as Candidate Biomarker of Mood Disorders—Longitudinal Study in Adolescent and Young Adult Patients. J. Clin. Med. 2021, 10, 4064.
https://doi.org/10.3390/jcm10184064
AMA Style
Skibinska M, Kapelski P, Dmitrzak-Weglarz M, Lepczynska N, Pawlak J, Twarowska-Hauser J, Szczepankiewicz A, Rajewska-Rager A.
Elevated Epidermal Growth Factor (EGF) as Candidate Biomarker of Mood Disorders—Longitudinal Study in Adolescent and Young Adult Patients. Journal of Clinical Medicine. 2021; 10(18):4064.
https://doi.org/10.3390/jcm10184064
Chicago/Turabian Style
Skibinska, Maria, Pawel Kapelski, Monika Dmitrzak-Weglarz, Natalia Lepczynska, Joanna Pawlak, Joanna Twarowska-Hauser, Aleksandra Szczepankiewicz, and Aleksandra Rajewska-Rager.
2021. "Elevated Epidermal Growth Factor (EGF) as Candidate Biomarker of Mood Disorders—Longitudinal Study in Adolescent and Young Adult Patients" Journal of Clinical Medicine 10, no. 18: 4064.
https://doi.org/10.3390/jcm10184064
APA Style
Skibinska, M., Kapelski, P., Dmitrzak-Weglarz, M., Lepczynska, N., Pawlak, J., Twarowska-Hauser, J., Szczepankiewicz, A., & Rajewska-Rager, A.
(2021). Elevated Epidermal Growth Factor (EGF) as Candidate Biomarker of Mood Disorders—Longitudinal Study in Adolescent and Young Adult Patients. Journal of Clinical Medicine, 10(18), 4064.
https://doi.org/10.3390/jcm10184064
